CKD remains a global problem, and early screening may help reduce comorbidities associated with this condition. As a future nurse practitioner, I advocate for more people to be screened early for CKD. It is possible to delay or prevent the development of ESKD and lessen cardiovascular consequences by identifying and treating individuals who have CKD at an early stage (Ng & Li, 2018). It permits treatments and prevents unnecessary exposure to nephrotoxic substances, reducing CKD progress to ESKD. As a future nurse practitioner, I will advise patients to avoid drugs that may cause damage to the kidney tubule. These drugs may even include the common OTC drugs, such as NSAIDs, which, when taken in large quantities, induce ARF that may cause CKD and CRF. Early screening for CKD may also identify significant risk factors for unfavorable outcomes, such as cardiovascular disease.
Patients can thus be offered education on their dietary management to avoid worsening the condition. The nurse might provide the patient with recommendations on selecting and preparing lower-sodium meals. A future nurse practitioner is uniquely positioned to advise patients on their diet (Luyckx et al., 2020). The diet may be altered so that the patient consumes more heart-healthy food. If diabetes and hypertension are poorly managed, they are significant factors in developing CKD (Mohan & Damjanov, 2019). I will advise the patients to adhere to their medication prescription if they are diabetic or hypertensive.
Renal failure and cardiovascular disease are more likely to occur in patients with CKD. Early screening reduces the risk of the patient suffering from these conditions. Earlier screening may prevent the patient from undergoing a renal transplant, thus saving the patient’s family economic expenses (Salvadori & Tsalouchos, 2017). Proper kidney transplant planning and the correct administration of drugs may be made possible by early identification of CKD with lower GFR. The nation may feel the economic impact as it reduces the amount spent on treating CKD patients; these finances may be invested in other sectors.
References
Luyckx, V. A., Cherney, D. Z. I., & Bello, A. K. (2020). Preventing CKD in developed countries. Kidney International Reports, 5(3), 263–277. Web.
Mohan, H., & Damjanov, I. (2019). Textbook of pathology. Jaypee Brothers Medical Publishers.
Ng, J. K-C., & Li, P. K-T. (2018). Chronic kidney disease epidemic: How do we deal with it? Nephrology, 23, 116–120. Web.
Salvadori, M., & Tsalouchos, A. (2017). Biomarkers in renal transplantation: An updated review. World Journal of Transplantation, 7(3), 161. Web.